The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative effectiveness of tumor response assessment methods: Standard-of-care versus computer-assisted response evaluation.
 
Brian Allen
No Relationships to Disclose
 
Edward Florez
No Relationships to Disclose
 
Reza Sirous
No Relationships to Disclose
 
Seth T Lirette
No Relationships to Disclose
 
Michael Griswold
No Relationships to Disclose
 
Erick M. Remer
No Relationships to Disclose
 
Zhen J. Wang
No Relationships to Disclose
 
Jacob E Bieszczad
No Relationships to Disclose
 
Kelly L Cox
No Relationships to Disclose
 
Ajit H. Goenka
No Relationships to Disclose
 
Candace M Howard-Claudio
No Relationships to Disclose
 
HyunSeon Kang
No Relationships to Disclose
 
Sadhna B Nandwana
No Relationships to Disclose
 
Rupan Sanyal
No Relationships to Disclose
 
Atul B. Shinagare
No Relationships to Disclose
 
J. Clark Henagen
No Relationships to Disclose
 
Judd Storrs
No Relationships to Disclose
 
Matthew S. Davenport
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Andrew Dennis Smith
Leadership - Color Enhanced Detection LLC; eMASS LLC; Liver Nodularity LLC; Radiostics LLC
Stock and Other Ownership Interests - Color Enhanced Detection LLC; eMASS LLC; Liver Nodularity LLC; Radiostics LLC
Research Funding - Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending "Computer-assisted tumor response assessment and evaluation of the vascular tumor burden"; Patent pending "Method for detection and staging of liver fibrosis from image acquired data" (Inst); Patent pending "Method for standardization and color enhanced detection (CED) for CT imaging" (Inst)